Drug intelligence / Profile preview

Seirogan Quick C

Development stage
Unknown
Lead developer
Taiko Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Seirogan Quick C is an oral antidiarrheal medication developed by Taiko Pharmaceutical, featuring wood creosote as its sole active ingredient. Unlike the traditional Seirogan pill formulation, which contains multiple botanical extracts, Quick C is delivered in a liquid-filled soft capsule designed for rapid dissolution and faster onset of action. Wood creosote, a mixture of phenolic compounds derived from wood tar, exerts its therapeutic effect by normalizing intestinal water metabolism—specifically by inhibiting excess fluid secretion and promoting absorption—and by regulating intestinal motility without suppressing natural peristalsis. It is widely used in Japan as an over-the-counter treatment for diarrhea, food poisoning, and water-induced distress. Clinical research, including the jRCTs041220146 trial, is currently evaluating its efficacy in managing metformin-induced gastrointestinal side effects, such as diarrhea, in patients with type 2 diabetes.

Brand names
Seirogan Quick CSeirogan
Other names
wood creosotemedicinal creosoteJP Wood Creosote
02

Targets

Acetylcholinesterase

Beyond the preview

Go deeper on Seirogan Quick C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seirogan Quick C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call